NCT00394095View on ClinicalTrials.gov

Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Bipolar DisorderWeight Gain
Interventions
DRUG

Topiramate

Oral topiramate 300-400mg/day for 12 weeks

DRUG

Placebo

Matched placebo to Experimental arm

Trial Locations (1)

45267-0559

University of Cincinnati Medical Center, Cincinnati

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Cincinnati

OTHER

NCT00394095 - Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine | Biotech Hunter | Biotech Hunter